Equity Overview
Price & Market Data
Price: $0.0863
Daily Change: $0.00 / 0.00%
Range: $0.0789 - $0.0873
Market Cap: $3,933,631
Volume: 24,000
Performance Metrics
1 Week: 37.10%
1 Month: 71.52%
3 Months: -21.80%
6 Months: -27.68%
1 Year: 5.34%
YTD: -28.76%
Details
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety, ADHD, non-neurological conditions of cancer, and non-alcoholic steatohepatitis. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.